Meloxicam
Rank #350 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$28.6M
Total Cost
4,714,084
Total Claims
$28.6M
Total Cost
86,918
Prescribers
$6
Cost per Claim
1,612,062
Beneficiaries
7,792,336
30-Day Fills
$329
Avg Cost/Provider
54
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$28.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $28.6M total
🔎 Data Overview
At $6.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Meloxicam
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Rikki Scoggin | Family Practice | Ada, OK | 306 | $25K |
| 2 | Evangeline Emesue | Internal Medicine | Harrisburg, PA | 262 | $20K |
| 3 | Sherif Nasef | Rheumatology | Yuma, AZ | 1,910 | $18K |
| 4 | Rachel Voeghtly | Nurse Practitioner | Altoona, PA | 192 | $14K |
| 5 | Zarine Ter-Poghosyan | Family Practice | Burbank, CA | 1,404 | $14K |
| 6 | Chau Le | Internal Medicine | Rosemead, CA | 1,270 | $14K |
| 7 | Arutyun Topsakalyan | General Practice | Glendale, CA | 1,232 | $11K |
| 8 | Daniel Serrato | Pain Management | Columbus, GA | 2,307 | $11K |
| 9 | Mitchell Davis | Family Practice | Ada, OK | 88 | $11K |
| 10 | Alexander Frank | Family Practice | Oklahoma City, OK | 919 | $10K |
| 11 | Anahit Blikian | General Practice | Glendale, CA | 883 | $10K |
| 12 | Xiandong Shi | Internal Medicine | Flushing, NY | 1,388 | $10K |
| 13 | Enrique Rodriguez | Internal Medicine | Lubbock, TX | 269 | $9,852 |
| 14 | Fausto Gonzalez | Internal Medicine | South Ozone Park, NY | 798 | $9,794 |
| 15 | Gerald Ho | Rheumatology | La Palma, CA | 911 | $9,762 |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 347 | Ivosidenib (Tibsovo) | $28.9M | 931 |
| 348 | Cyclobenzaprine Hcl (Cyclobenzaprine Hcl) | $28.7M | 2,582,519 |
| 349 | Atenolol (Atenolol) | $28.6M | 2,717,988 |
| 350 | Meloxicam (Meloxicam) | $28.6M | 4,714,084 |
| 351 | Triamcinolone Acetonide (Triamcinolone Acetonide) | $28.5M | 2,307,130 |
| 352 | Pitolisant Hcl (Wakix) | $28.4M | 2,361 |
| 353 | Olanzapine/Samidorphan Malate (Lybalvi) | $28.3M | 18,294 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology